Zacopride
Alternative Names: AHR 11190; AHR 11190B; MD 780209Latest Information Update: 22 Jan 1997
At a glance
- Originator Delalande
- Developer AH Robins; Delalande
- Class Antiemetics; Benzamides; Drug withdrawal therapies
- Mechanism of Action Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Cognition disorders; Major depressive disorder; Nausea and vomiting; Psychotic disorders
Most Recent Events
- 22 Jan 1997 Discontinued-Unspecified phase in Depression in USA (PO)
- 22 Jan 1997 Discontinued-Unspecified phase in Emesis in USA (PO)
- 25 Jun 1996 Discontinued-Unspecified phase in Cognition disorders in USA (PO)